Some argue that the settlement — which has not yet been approved by the court — will fuel price hikes for generative AI ...

I-evuzamitide, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients suspected of or diagnosed with cardiac ...